Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

Characterization and Nucleotide Sequence of CARB-6, a New Carbenicillin-Hydrolyzing β-Lactamase from Vibrio cholerae

Danièle Choury, Gérald Aubert, Marie-France Szajnert, Kemal Azibi, Marc Delpech, Gérard Paul
Danièle Choury
Laboratoire de Biologie Moléculaire des Cellules Eucaryotes,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gérald Aubert
Laboratoire de Bactériologie, CHU, Saint-Etienne, France, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-France Szajnert
INSERM U129, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kemal Azibi
INSERM U129, and
CHU Alger-Ouest, Algiers, Algeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Delpech
Laboratoire de Biologie Moléculaire des Cellules Eucaryotes,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gérard Paul
Laboratoire de Recherche en Microbiologie, UFR Cochin Port-Royal, 75014 Paris, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.43.2.297
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

A clinical strain of Vibrio cholerae non-O1 non-O139 isolated in France produced a new β-lactamase with a pI of 5.35. The purified enzyme, with a molecular mass of 33,000 Da, was characterized. Its kinetic constants show it to be a carbenicillin-hydrolyzing enzyme comparable to the five previously reported CARB β-lactamases and to SAR-1, another carbenicillin-hydrolyzing β-lactamase that has a pI of 4.9 and that is produced by a V. cholerae strain from Tanzania. This β-lactamase is designated CARB-6, and the gene for CARB-6 could not be transferred to Escherichia coli K-12 by conjugation. The nucleotide sequence of the structural gene was determined by direct sequencing of PCR-generated fragments from plasmid DNA with four pairs of primers covering the whole sequence of the reference CARB-3 gene. The gene encodes a 288-amino-acid protein that shares 94% homology with the CARB-1, CARB-2, and CARB-3 enzymes, 93% homology with the Proteus mirabilis N29 enzyme, and 86.5% homology with the CARB-4 enzyme. The sequence of CARB-6 differs from those of CARB-3, CARB-2, CARB-1, N29, and CARB-4 at 15, 16, 17, 19, and 37 amino acid positions, respectively. All these mutations are located in the C-terminal region of the sequence and at the surface of the molecule, according to the crystal structure of theStaphylococcus aureus PC-1 β-lactamase.

Clinical strains of Vibrio cholerae are naturally susceptible in vitro to broad-spectrum penicillins and cephalosporins. Some isolates that exhibit plasmid-mediated resistance to β-lactams that are susceptible to the effects of β-lactamase inhibitors produce TEM-1 (9, 11, 35) or SAR-1, a carbenicillin-hydrolyzing β-lactamase with an isoelectric point of 4.9 (29).

Until 1992, V. cholerae of serogroup O1 was the only known causative agent of pandemic cholera. Strains termed non-O1 had never been shown to generate epidemic cholera, although some were responsible for sporadic gastrointestinal or extraintestinal diseases, such as pyogenic infection and septicemia in susceptible hosts (24, 30). However, a non-O1 strain is causing the current cholera pandemic described in Bangladesh. The strain is V. choleraeO139, which was initially isolated in southern Asia (34).

We report here the biochemical and structural properties of a new β-lactamase produced by a clinical strain of V. choleraenon-O1, non-O139 that is resistant to β-lactams and that was responsible for the death of a cirrhotic patient after a lower-limb infection (3). The strain was isolated at Bellevue Hospital (CHU, Saint-Etienne, France).

In preliminary studies, the β-lactamase was shown to have a pI of 5.35 and to be inhibited by an anti-CARB-3 serum (3) that inactivates the five previously described enzymes (27). We report here the physical and biochemical properties of the purified enzyme. The nucleotide sequence of the gene and the deduced amino acid composition of this β-lactamase were determined and compared to those of other β-lactamases.

(This work was presented, in part, at the 16th and 17th Interdisciplinary Meetings of Anti-Infectious Chemotherapy, Paris, France, in 1996 [5] and 1997 [6], respectively.)

MATERIALS AND METHODS

Clinical strain.The clinical strain of V. cholerae non-O1, non-O139 used in this study was resistant to aminopenicillins and carboxypenicillins and was isolated from a cirrhotic French farmer at the Bellevue Hospital (CHU, Saint-Etienne, France). This strain was responsible for a fatal septic shock as a consequence of a severe infection of the right leg that developed within 2 weeks after a stay on the Mediterranean coast (3).

β-Lactamase purification and analytical IEF.The β-lactamase extract was prepared from 24 liters (92 g [wet weight]) of an overnight culture grown in nutrient broth (Difco) with amoxicillin (50 μg/ml). The cells were collected by centrifugation and broken by sonication at 4°C (100 W at 20 kHz) in 50 mM Tris HCl buffer (pH 7) containing 2 mM EDTA, 7 mM β-mercaptoethanol, and 10% sucrose. The sample was centrifuged at 20,000 rpm (Sorvall RC2B) for 20 min, and the supernatant containing the β-lactamase was collected. The enzyme was purified by ammonium sulfate precipitation to between 40 and 80% saturation, ion-exchange chromatography (DE 52), and gel filtration on 5% acrylamide and 4% agarose (Ultrogel AcA54; IBF-BIOSEPRA). The purified enzyme was concentrated by ultrafiltration (26). Purity was verified by sodium dodecyl sulfate (SDS)-electrophoresis (19). Analytical isoelectric focusing (IEF) was carried out in a polyacrylamide gel with an Ampholine (Pharmacia) gradient (pH 3.5 to 9.5) (20). The β-lactamase in the gel was revealed by the iodine procedure in the presence of benzylpenicillin (17). The pI of the enzyme was determined by using TEM-1 (R111) and PSE-4 (16, 23) as reference β-lactamases.

Molecular weight.The molecular weight was determined by SDS-gel electrophoresis (19).

Substrate and inhibitor profiles of the β-lactamase.The following antibiotics and β-lactamase inhibitors were used to determine kinetic constants: benzylpenicillin (Sarbach); amoxicillin, ticarcillin, clavulanic acid, and cloxacillin (Smith Kline Beecham); piperacillin and tazobactam (Lederlé); methicillin and oxacillin (Bristol-Myers); cephaloridine (Glaxo); sulbactam (Pfizer); cephalothin (Panpharma); and mezlocillin (Bayer).

Kinetic parameters (Km and relative Vmax) were determined and inhibitor studies were performed at pH 7 and 37°C with a pH Stat apparatus by the microacidimetric method (15). One β-lactamase unit is defined as the amount of enzyme that hydrolyzes 1 μmol of benzylpenicillin per min at pH 7 and 37°C.

Preparation of DNA for PCR.Plasmid DNA was extracted and purified by the X-Trax procedure (Medgene Science).

PCR amplification and nucleotide sequencing.The nucleotide sequence was determined by direct sequencing of PCR-generated DNA fragments with four pairs of synthetic primers (Table1) covering the whole reference sequence of CARB-3 gene (18). The first fragment (V2-V2′) was obtained by the nested PCR method (Fig.1).

View this table:
  • View inline
  • View popup
Table 1.

Oligonucleotide primers used for PCR amplification

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Sequencing strategy for CARB-6 β-lactamase gene. The CARB-6 gene is represented by the black box. The arrows indicate the oligonucleotide positions.

Amplification by PCR with specific primers was performed with 10 μl of the plasmid DNA preparation and 2 μl of each primer solution (100 ng/μl) in a reaction mixture with a total volume of 100 μl. The reaction mixture contained 10 μl of PCR buffer (GIBCO BRL), each deoxynucleoside triphosphate at a concentration of 0.2 mM, 4.5 mM MgCl2, and 2.5 U of Taq DNA polymerase (GIBCO BRL). The PCR program used was an initial denaturation step at 96°C for 5 min, followed by 30 cycles (50 s of denaturation at 96°C, 50 s of annealing at 55°C, and 50 s of extension at 72°C) and a final extension at 72°C for 7 min. Nested PCR amplification was performed with V1 and V1′ as the outer primer pair and V2 and V2′ as the inner primer pair (Table 1). One microliter of the PCR product obtained with the outer primer pair was used for the PCR with the inner primer pair under the conditions described above. Amplifications were carried out on a Perkin-Elmer Cetus apparatus, and the products were analyzed on 2% agarose gels.

The PCR products were sequenced with an automatic sequencer (ABI 377) by using a dye terminator cycle sequencing kit (Ready Reaction 402080) with Ampli Taq polymerase (Fluorescent Sequencing).

Sequence analysis.The BLASTN program for nucleic acid databases (GenBank, EMBL) and the BLASTP program for amino acid database (SwissProt) were used to search for related β-lactamases with sequences homologous to that of the purified β-lactamase through the World Wide Web BLAST server of the National Center for Biotechnology Information (1). Multiple sequence alignments were performed with the CLUSTALW facilities of the BISANCE software package in the INFOBIOGEN server (8, 33).

The InsightII program was used for molecular modeling of theStaphylococcus aureus PC-1 β-lactamase molecule.

Nucleotide sequence accession number.The CARB-6 β-lactamase sequence has been submitted to GenBank. Its accession no. is AF 030945.

RESULTS

Purification and molecular weight determination.The enzyme was purified 200-fold, and the yield was 10%. Its molecular weight was estimated to be 33,000 (Table 2).

View this table:
  • View inline
  • View popup
Table 2.

Physicochemical properties of the CARB-6 β-lactamase ofV. cholerae and comparison with TEM-1 and other carbenicillin-hydrolyzing enzymes

pI.The β-lactamase, both as a crude extract and after purification, was subjected to IEF. In both cases a single band was obtained at pI 5.35, which is between those of TEM-1 (pI 5.4) and PSE-4 (CARB-1) (pI 5.3) (Table 2).

Substrate and inhibition profiles.The substrate and inhibition profiles of the purified enzyme were determined (Tables3 and 4). They indicate that it is a penicillinase which hydrolyzes ticarcillin and mezlocillin (59 and 100% hydrolysis relative to that for penicillin, respectively). The Km values indicate that the purified enzyme has a higher affinity for carboxypenicillins such as ticarcillin (55 μM) and ureidopenicillins such as mezlocillin (58.5 μM) than for benzylpenicillin (96 μM) and amoxicillin (157 μM) (Table 3).

View this table:
  • View inline
  • View popup
Table 3.

Kinetic parameters for V. cholerae CARB-6 β-lactamase in comparison with the published values for β-lactamases TEM-1, SAR-1, and CARB-1 to CARB-3a

View this table:
  • View inline
  • View popup
Table 4.

Effects of chemical and β-lactam inhibitors on CARB-6, SAR-1, and TEM-1 β-lactamasesa

The inhibition profile is compatible with that of a class A β-lactamase (Table 4).

Sequence analysis.The nucleotide sequence of the PCR product obtained with consecutive primers (967 nucleotides) contains an open reading frame of 962 nucleotides. The coding region (CDS) of 867 nucleotides (positions 96 to 962) encodes a protein of 288 amino acids (Fig. 2 and3).

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

Gene sequence and deduced amino acid sequence of theV. cholerae β-lactamase (CARB-6). The deduced amino acid sequence is designated by the one-letter code. The active site,STFK, is boxed, and the differences relative to CARB-1 to CARB-3 are underlined.

Fig. 3.
  • Open in new tab
  • Download powerpoint
Fig. 3.

Multiple sequence alignment of the amino acid sequences of CARB-1, CARB-2, CARB-3, CARB-4, P. mirabilis N29,P. mirabilis GN79, and CARB-6 β-lactamases. The shadowed boxes (I to VII) correspond to amino acid boxes conserved in all penicillin-recognizing enzymes, as identified by Joris et al. (14). Alpha-helix and beta-barrel motifs are indicated from the PC-1 crystal structure (4, 12). Asterisks indicate the conserved residues specific for class A β-lactamases. Amino acid changes are written as black letters in white boxes. Sequences are numbered as described by Ambler (2).

The deduced amino acid sequence is very similar to those of class A β-lactamases: a bla active-site (STFK) tetrad at positions 65 to 68 (positions 70 to 73 according to the standard numbering scheme of Ambler [2]), cysteine residues at positions 72 and 118 (Ambler positions 77 and 123), and all seven conserved amino acid boxes (4, 14) and specific conserved residues (Fig. 3).

Nucleic and amino acid analyses with the BLAST and FASTA programs showed the purified enzyme has substantial homology (94%) with the CARB-1, CARB-2, and CARB-3 β-lactamases of the same group. The starting codon and the length of the coding region (288 amino acids) are strictly conserved (Fig. 2).

Multiple sequence alignment of the CARB-6 amino acid sequence with the sequences of the previously described CARB-1, CARB-2, and CARB-3 (16, 18), CARB-4 (28, 32), and Proteus mirabilis N29 (13) β-lactamases confirms that it is a carbenicillinase. Moreover, CARB-6 possess an RSG box VII that is encountered only in this class of β-lactamases. It appears to be more closely related to CARB-3, CARB-2, CARB-1, and N29 than to CARB-4 (Fig.3). The nucleotide and amino acid sequences of CARB-6 and CARB-3 are very similar. CARB-6 differs from CARB-3 at 15 amino acid positions (Table 5) located in the downstream third of the sequence (Fig. 2). By molecular modeling with the known crystal coordinates of the S. aureus PC-1 enzyme (12), these mutations were localized on the surface of the molecule.

View this table:
  • View inline
  • View popup
Table 5.

Amino acid point mutations in β-lactamases CARB-1, CARB-2, CARB-3, and CARB-6

DISCUSSION

V. cholerae strains belonging to antigenic group O1 were the etiologic agents of the first seven cholera pandemics, and O139 strains are the etiologic agents of the current pandemic. Some non-O1, non-O139 isolates of V. cholerae are responsible for sporadic intestinal or extraintestinal noncholera infections. Generally, wild-type strains of V. cholerae are naturally susceptible to antibiotics that are active against gram-negative bacteria, but biotype El Tor is resistant to polymyxins. However, acquired multiple-drug resistance, presumably plasmid mediated, may occur (9, 11, 25, 29, 35). Moreover,blaCARB and blaPSE genes are known to be plasmid mediated (22) and to be part of transposons and integrons (4).

The phenotypic expression of plasmid-mediated β-lactamase production by strains is resistance to aminopenicillins and carboxypenicillins, but no interference with cephalosporin activities occurs. β-Lactamase inhibitors such as clavulanic acid can restore susceptibility to inactive penicillins. These characteristics are consistent with the presence of TEM-1 or SAR-1, as reported previously for resistant strains. However, a pyogenic strain of V. cholerae non-O1, non-O139 expressed the same resistance phenotype, but its phenotype was associated with the production of a new β-lactamase of pI 5.35. Indeed, the pI was clearly different from that of SAR-1 (pI 4.9) but was similar to that of TEM-1 (pI 5.4) (29). Conversely, its kinetic constants identify this enzyme as a carbenicillin-hydrolyzing enzyme similar to SAR-1 but different from TEM-1 (16, 21). Finally, the same substrates are similarly hydrolyzed by CARB-6, CARB-1 to CARB-3, and SAR-1, but the affinity of CARB-6 for most substrates except for piperacillin (50% inhibition) is slightly lower than those of the CARB β-lactamases. The inhibition profile reveals that clavulanic acid, an inhibitor of class A β-lactamases, inhibits CARB-6, as well as SAR-1 and TEM-1. If CARB-6 is compared to β-lactamases not yet found in V. cholerae strains, the enzyme with the nearest pI (pI 5.3), molecular mass (33,000 Da) (Table2), and substrate profile is CARB-1 (PSE-4) (16, 21).

The resistance gene could not be transferred by conjugation to the recipient Escherichia coli K-12 strain, despite several attempted mating experiments. This inability to be transferred by conjugation is a character often reported for the V. cholerae and other CARB or CARB-like genes (35).

Initially, only the TEM-1 enzyme was found in ampicillin-resistantV. cholerae (9, 10). Later, a novel β-lactamase designated SAR-1 was reported in a strain of V. cholerae(29). Twenty-nine strains isolated in Africa have been studied in order to assess the distribution of resistance genes inV. cholerae (25). None of the β-lactam-resistant isolates studied cross-hybridized with oligonucleotide probes specific for TEM-1 or OXA-1 β-lactamases. This confirms the presence of β-lactamases other than TEM-1 in V. cholerae.

Most CARB β-lactamases were described as beingPseudomonas-specific enzymes, hence the designation PSE. This indicates that they were originally identified inPseudomonas aeruginosa strains (28). Indeed, these enzymes have rarely been reported in members of the familyEnterobacteriaceae (22) and have been reported only once in Achromobacter xylosoxidans (7). No structural information is available for SAR-1, which is found inV. cholerae, or for CARB-5, which is found in members of theAcinetobacter genus (27). The two carbenicillin-hydrolyzing enzymes described in Japan from P. mirabilis are antigenically and structurally unrelated (Fig. 3): that from strain N29 is a variant of the CARB group of enzymes (13), while that from strain GN79 has a distant relationship with these enzymes but contains the important Arg-234 CARB signature (31). The AER-1 β-lactamase produced by a strain ofAeromonas hydrophila is also a structurally unique carbenicillin-hydrolyzing enzyme (32). A feature common to all bacterial species that produce these β-lactamases is their distribution in an aquatic environment.

Nucleotide sequencing, analysis, and comparison of the amino acid sequence of CARB-6 with those of other members of the β-lactamase family showed the presence of the seven boxes described by Joris et al. (14) and the active-site tetrad characteristic of class A β-lactamases, according to the classification scheme of Ambler (2). Multiple sequence alignment with class A β-lactamase amino acid sequences confirmed the relatedness of CARB-6 to carbenicillinases. The amino acid substitutions that characterize the CARB-6 sequence make this enzyme more similar to P. mirabilis N29, CARB-1, CARB-2, and CARB-3 β-lactamases (19, 17, 16, and 15 amino acid differences, respectively) than to the CARB-4 β-lactamase (38 amino acid differences) (Fig. 3 and Table 5). Identification of these mutated positions on the 2-Å crystal structure of the S. aureus penicillinase showed that all of them are located on the surface of the protein. These changes would therefore be expected to modify the function of the enzyme rather than its structure and are consistent with faster amoxicillin hydrolysis (higher Vmax) and a lower affinity for all β-lactam substrates (higher Km) (Table 3). Further analysis may elucidate the mechanisms by which these mutations affect enzyme function.

In conclusion, CARB-6, described for the first time in V. cholerae, appears to be a new carbenicillin-hydrolyzing enzyme with a unique combination of enzymatic and physicochemical properties.

ACKNOWLEDGMENTS

We thank I. Siebert for efficient technical assistance, F. Letourneur (ICGM) for the nucleotide sequencing, and L. Camoin (UPR 415, ICGM) for fruitful help with and discussions about the modeling experiments.

FOOTNOTES

    • Received 28 May 1998.
    • Returned for modification 21 September 1998.
    • Accepted 20 November 1998.
  • Copyright © 1999 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Altschul S. F.,
    2. Thomas L. M.,
    3. Schaffer A. A.,
    4. Zhang J.,
    5. Zhang Z.,
    6. Miller W.,
    7. Lipman D. J.
    Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25 1997 3389 3402
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Ambler R. P.
    The structure of β-lactamases. Philos. Trans. R. Soc. London Biol. 289 1980 321 331
    OpenUrlCrossRef
  3. 3.↵
    1. Aubert G.,
    2. Zambardi G.,
    3. Zeni F.,
    4. Paul G.,
    5. Fournier J. M.,
    6. Oulahal N.,
    7. Vermesch R.
    Abstract presented at the 7th International Congress for Infectious Diseases 1996
  4. 4.↵
    1. Boissinot M.,
    2. Levesque R. C.
    Nucleotide sequence of the PSE-4 carbenicillinase gene and correlations with the Staphylococcus aureus PC-1 β-lactamase crystal structure. J. Biol. Chem. 265 1990 1225 1230
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Choury D.,
    2. Aubert G.,
    3. Siebert I.,
    4. Assous M.,
    5. Névot P.,
    6. Paul G.
    Abstract presented at the 16th Interdisciplinary Meeting of Anti-Infectious Chemotherapy 1996
  6. 6.↵
    1. Choury D.,
    2. Aubert G.,
    3. Szajnert M. F.,
    4. Assous M.,
    5. Blanchard H.,
    6. Delpech M.,
    7. Paul G.
    Abstract presented at the 17th Interdisciplinary Meeting of Anti-Infectious Chemotherapy 1997
  7. 7.↵
    1. Decré D.,
    2. Arlet G.,
    3. Bergogue-Bérézin E.,
    4. Philippon A.
    Identification of a carbenicillin-hydrolyzing β-lactamase in Alcaligenes denitrificans subsp. xylosoxidans. Antimicrob. Agents Chemother. 39 1995 771 774
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Dessen P.,
    2. Fondrat C.,
    3. Valencien C.,
    4. Mugnier C.
    BISANCE: a French service for access to biomolecular sequence databases. Comput. Appl. Biosci. 6 1990 355 356
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Dupont M. J.,
    2. Jouvenot M.,
    3. Couetdic G.,
    4. Michel-Briand Y.
    Development of plasmid-mediated resistance in Vibrio cholerae during treatment with trimethoprim-sulfamethoxazole. Antimicrob. Agents Chemoter. 27 1985 280 281
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Hedges R. W.,
    2. Jacobs A. E.
    A 98-megadalton R factor of compatibility group C in a Vibrio cholerae El Tor isolated from southern USSR. J. Gen. Microbiol. 89 1975 383 386
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Hedges R. W.,
    2. Vialard J. L.,
    3. Pearson N. J.,
    4. O’Grady F.
    R plasmids from asian strains of Vibrio cholerae. Antimicrob. Agents Chemother. 11 1977 585 588
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Herzberg O.
    Refined crystal structure of β-lactamase from Staphylococcus aureus PC-1 at 2Å resolution. J. Mol. Biol. 217 1991 701 719
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Ito Y.,
    2. Hirano T.
    Carbenicillin-hydrolyzing penicillinase mediated by a plasmid of Proteus mirabilis and its relationship to the PSE-type enzymes of Pseudomonas aeruginosa. J. Appl. Microbiol. 83 1997 175 180
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Joris B.,
    2. Ghuysen J. M.,
    3. Dive G.,
    4. Renard A.,
    5. Dideberg O.,
    6. Charlier P.,
    7. Frère J. M.,
    8. Kelly J. A.,
    9. Boyington J. C.,
    10. Moews P. C.,
    11. Knox J. R.
    The active-site-serine penicillin-recognizing enzymes as members of the Streptomyces R61 dd-peptidase family. Biochem. J. 250 1988 313 324
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Kazmierczak A.,
    2. Philippon A.,
    3. Chardon H.,
    4. Labia R.,
    5. Le Goffic F.
    Constantes cinétiques (Km et Vmax) des β-lactamases mesurées par une méthode micro-acidimétrique couplée à l’ordinateur. Ann. Microbiol. (Inst. Pasteur) 124B 1973 259 268
    OpenUrl
  16. 16.↵
    1. Labia R.,
    2. Guionie M.,
    3. Barthélémy M.,
    4. Philippon A.
    Properties of three carbenicillin-hydrolyzing β-lactamases (CARB) from Pseudomonas aeruginosa: identification of a new enzyme. J. Antimicrob. Chemother. 7 1981 49 56
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Labia R.,
    2. Barthélémy M.
    L’enzymogramme des β-lactamases: adaptation en gel de la méthode iodométrique. Ann. Microbiol. (Inst. Pasteur) 130B 1979 295 304
    OpenUrl
  18. 18.↵
    1. Lachapelle J.,
    2. Dufresnes J.,
    3. Levesque R. C.
    Characterization of the blaCARB-3 gene encoding the carbenicillinase-3 β-lactamase of Pseudomonas aeruginosa. Gene 102 1991 7 12
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Laemmli U. K.
    Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 1970 680 685
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Matthew M.,
    2. Harris A. M.,
    3. Marshall M. J.,
    4. Ross G. W.
    The use of analytical isoelectric focusing for detection and identification of β-lactamases. J. Gen. Microbiol. 88 1975 169 178
    OpenUrlPubMed
  21. 21.↵
    1. Medeiros A. A.
    β-Lactamases. Br. Med. Bull. 40 1984 18 27
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Medeiros A. A.,
    2. Hedges R. W.,
    3. Jacoby G. A.
    Spread of “Pseudomonas-specific” β-lactamase to plasmids of enterobacteria. J. Bacteriol. 149 1982 700 707
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Michel-Briand Y.,
    2. Bruant L.
    Etude de la production de β-lactamase pour la carbénicilline chez trente souches de Pseudomonas aeruginosa (mise en évidence d’une souche hautement résistante). C. R. Acad. Sci. Ser. D 275 1972 503 506
    OpenUrl
  24. 24.↵
    1. Morris J. G. J.
    Non O group 1 Vibrio cholerae strains not associated with epidemic didease Vibrio cholerae and cholera—molecular to global perspectives. Wachsmuth I. K., Blake P. A., Olsvik R. 1994 103 115 American Society for Microbiology Washington D.C
  25. 25.↵
    1. Ouellette M.,
    2. Gerbaud G.,
    3. Courvalin P.
    Genetic, biochemical and molecular characterization of strains of Vibrio cholerae multiresistant to antibiotics. Ann. Microbiol. (Inst. Pasteur) 139 1988 105 113
    OpenUrl
  26. 26.↵
    1. Paul G.,
    2. Gerbaud G.,
    3. Buré A.,
    4. Philippon A. M.,
    5. Paugon B.,
    6. Courvalin P.
    TEM-4, a new plasmid-mediated β-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli. Antimicrob. Agents Chemother. 33 1989 1958 1963
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Paul G.,
    2. Joly-Guillou M. L.,
    3. Bergogue-Bérézin E.,
    4. Nevot P.,
    5. Philippon A.
    Novel carbenicillin-hydrolyzing β-lactamase (CARB-5) from Acinetobacter calcoaceticus var. anitratus. FEMS Microbiol. Lett. 59 1989 45 50
    OpenUrlCrossRef
  28. 28.↵
    1. Philippon A.,
    2. Paul G.,
    3. Thibaut A.,
    4. Jacoby G.
    Properties of a novel carbenicillin-hydrolyzing β-lactamase (CARB-4) specified by an IncP-2 plasmid form. Antimicrob. Agents Chemother. 24 1986 362 369
    OpenUrl
  29. 29.↵
    1. Reid A. J.,
    2. Amyes S. G. B.
    Plasmid penicillin resistance in Vibrio cholerae: identification of new β-lactamase SAR-1. Antimicrob. Agents Chemother. 30 1986 245 247
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Safrin S.,
    2. Morris J. G.,
    3. Adams M.,
    4. Pons V.,
    5. Jacobs R.,
    6. Conte J. E.
    Non O1 Vibrio cholerae bacteremia: a case report and review. Rev. Infect. Dis. 10 1987 1012 1017
    OpenUrl
  31. 31.↵
    1. Sakurai Y.,
    2. Tsukamoto K.,
    3. Sawai T.
    Nucleotide sequence and characterization of a carbenicillin-hydrolyzing penicillinase gene from Proteus mirabilis. J. Bacteriol. 173 1991 7038 7041
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Sanschagrin F.,
    2. Bejaoui N.,
    3. Levesque R. C.
    Structure of CARB-4 and AER-1 carbenicillin-hydrolyzing beta-lactamases. Antimicrob. Agents Chemother. 42 1998 1966 1972
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Thompson J. D.,
    2. Higgins D. G.,
    3. Gibson T. J.
    CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22 1994 4673 4680
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    World Health Organization Epidemic diarrhea due to Vibrio cholerae non-O1. Weekly Epidemiol. Rec. 68 1993 141 142
    OpenUrlPubMed
  35. 35.↵
    1. Young H. K.,
    2. Nandivada L. S.,
    3. Amyes G. B.
    Antibiotic resistance in the tropics. 1. The genetics of bacterial ampicillin resistance in tropical areas. Trans. R. Soc. Trop. Med. Hyg. 83 1989 38 41
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Characterization and Nucleotide Sequence of CARB-6, a New Carbenicillin-Hydrolyzing β-Lactamase from Vibrio cholerae
Danièle Choury, Gérald Aubert, Marie-France Szajnert, Kemal Azibi, Marc Delpech, Gérard Paul
Antimicrobial Agents and Chemotherapy Feb 1999, 43 (2) 297-301; DOI: 10.1128/AAC.43.2.297

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Characterization and Nucleotide Sequence of CARB-6, a New Carbenicillin-Hydrolyzing β-Lactamase from Vibrio cholerae
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Characterization and Nucleotide Sequence of CARB-6, a New Carbenicillin-Hydrolyzing β-Lactamase from Vibrio cholerae
Danièle Choury, Gérald Aubert, Marie-France Szajnert, Kemal Azibi, Marc Delpech, Gérard Paul
Antimicrobial Agents and Chemotherapy Feb 1999, 43 (2) 297-301; DOI: 10.1128/AAC.43.2.297
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Carbenicillin
penicillins
Vibrio cholerae
beta-lactamases

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596